DASMED
ActiveSummary
DASMED has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €210,760 and a net result of €64,186. Equity is growing by ~52.4% per year across the filed fiscal years. The computed 12-month bankruptcy probability is 0.4% (very low).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 27 days late
2025
31-12
Financial
Liquidity triplescurrent ratio 5.30
Current ratio from 1.84 to 5.30; short-term debt falls from €63,109 to €18,924.
31-12
Financial
Equity above €200,000Eq €210,760 ▲43.8%
3 profitable years in a row build equity to €210,760.
30-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2023net €89,387 ▲71.3%
Operating result €108,605, net result €89,387, both a record.
31-12
Financial
Equity above €100,000Eq €146,574 ▲156%
2 profitable years in a row build equity to €146,574.
20-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 20 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.